To promote innovation in China’s cell therapy and immunotherapy fields, advance discussion of key scientific challenges, share the latest clinical research, and strengthen global collaboration and translational progress, the 2025…

To advance innovation in China’s cell and immunotherapy landscape, deepen exchanges on key scientific questions, and share the latest clinical research progress, the 2025 International Cell and Immunotherapy Conference (CTI 2025)—jointly organized by Zhejiang University, the International Academy for Clinical Hematology (IACH), the Zhejiang Society of Immunology, and the Zhejiang Anti-Cancer Association, and co-hosted by the First Affiliated Hospital of Zhejiang University School of Medicine and the Liangzhu Laboratory—was held in Hangzhou, Zhejiang, from November 13 to 16, 2025. 

To promote innovation in China’s cell and immunotherapy fields, facilitate in-depth exchange on key scientific issues, share the latest clinical research progress, and advance global collaboration and clinical translation, the…

We are pleased to share a featured interview from the Cellular Therapy and Immunotherapy Conference 2025 (CTI 2025) in Hangzhou, conducted in collaboration with Hematology Frontier. In this in-depth discussion,…

On November 2, 2025, Professors Michael R. Bishop, M.D. and Edmund Waller visited the Peking University Institute of Hematology for an academic exchange that included ward rounds, keynote lectures, and…